DRUGGING THE UNDRUGGABLE: PROGRAMMING OVARIAN CANCER CELLS AS THE NEXT-GENERATION IMMUNOTHERAPY

$1,046,135FY2025Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators